nach oben

Intensive Care Medicine

Erschienen in:

01.09.2015 | Understanding the Disease

Understanding toxic shock syndrome

verfasst von: Jason P. Burnham, Marin H. Kollef

Erschienen in: Intensive Care Medicine | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Excerpt

Toxic shock syndrome (TSS) is a fulminant Gram positive infection, typically due to Staphylococcus aureus or Streptococcus pyogenes, though small series have described similar syndromes in closely related pathogens, including group B, C, and G streptococci. The annual incidence of staphylococcal TSS (SaTSS) is about 0.5/100,000 and about 0.4/100,000 for streptococcal TSS (SeTSS), though local rates may vary [1, 2]. Mortality rates are below 5 % for menstrual SaTSS, 5–22 % for non-menstrual SaTSS, and 30–70 % for SeTSS [2‐5]. …

DeVries AS, Lesher L, Schlievert PM, Rogers T, Villaume LG, Danila R, Lynfield R (2011) Staphylococcal toxic shock syndrome 2000–2006: epidemiology, clinical features, and molecular characteristics. PLoS One 6:e22997PubMedCentralCrossRefPubMed

Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalen C, Jasir A (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46:2359–2367PubMedCentralCrossRefPubMed

Kain KC, Schulzer M, Chow AW (1993) Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses. Clin Infect Dis 16:100–106CrossRefPubMed

Descloux E, Perpoint T, Ferry T, Lina G, Bes M, Vandenesch F, Mohammedi I, Etienne J (2008) One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis 27:37–43CrossRefPubMed

Hajjeh RA, Reingold A, Weil A, Shutt K, Schuchat A, Perkins BA (1999) Toxic shock syndrome in the United States: surveillance update, 1979 1996. Emerg Infect Dis 5:807–810PubMedCentralCrossRefPubMed

Centers for Disease Control and Prevention (2011) Toxic shock syndrome (other than streptococcal) (TSS); 2011 case definition. http://wwwn.cdc.gov/nndss/conditions/toxic-shock-syndrome-other-than-streptococcal/case-definition/2011/. Accessed 3 Apr 2015

Parsonnet J, Hansmann MA, Delaney ML, Modern PA, Dubois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, Onderdonk AB (2005) Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol 43:4628–4634PubMedCentralCrossRefPubMed

Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE (1996) Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335:547–554CrossRefPubMed

Centers for Disease Control and Prevention (2010) Streptococcal toxic-shock syndrome (STSS) (Streptococcus pyogenes); 2010 case definition. http://wwwn.cdc.gov/nndss/conditions/streptococcal-toxic-shock-syndrome/case-definition/2010/. Accessed 3 Apr 2015

10.

Holm SE, Norrby A, Bergholm AM, Norgren M (1992) Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988–1989. J Infect Dis 166:31–37CrossRefPubMed

11.

Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B (2005) Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352:1445–1453CrossRefPubMed

12.

Schlievert PM (1986) Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet 1:1149–1150CrossRefPubMed

13.

Lee VT, Chang AH, Chow AW (1992) Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates. J Infect Dis 166:911–915CrossRefPubMed

14.

Stevens DL, Wallace RJ, Hamilton SM, Bryant AE (2006) Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. Clin Infect Dis 42:729–730CrossRefPubMed

15.

Carapetis JR, Jacoby P, Carville K, Ang SJ, Curtis N, Andrews R (2014) Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis 59:358–365CrossRefPubMed

16.

Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE (2007) Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis 195:202–211CrossRefPubMed

17.

Coyle EA, Cha R, Rybak MJ (2003) Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release. Antimicrob Agents Chemother 47:1752–1755PubMedCentralCrossRefPubMed

18.

Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37:333–340CrossRefPubMed

19.

Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A (2014) Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis 59:851–857CrossRefPubMed

20.

Matsushima A, Kuroki Y, Nakajima S, Sakai T, Kojima H, Ueyama M (2014) Low level of TSST-1 antibody in burn patients with toxic shock syndrome caused by methicillin-resistant Staphylococcus aureus. J Burn Care Res. doi:10.1097/BCR.0000000000000128

Titel: Understanding toxic shock syndrome
verfasst von: Jason P. Burnham
Marin H. Kollef
Publikationsdatum: 01.09.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Intensive Care Medicine / Ausgabe 9/2015
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-015-3861-7

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Understanding toxic shock syndrome

Excerpt

Neu im Fachgebiet AINS

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2015

Early goal-directed therapy: from discovery through enthusiasm to equipoise?

Fluid challenges in intensive care: the FENICE study

Early goal-directed therapy versus “early”, “goal-directed” therapy

Resuscitation fluid use in Australian and New Zealand Intensive Care Units between 2007 and 2013

What’s new in sedation strategies?

Corticosteroids for paediatric ARDS: unjustified—even unjustifiable?

Neu im Fachgebiet AINS

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS